Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riociguat vs phosphodiesterase-5 inhibitors in cardiovascular disease
jRCT1080223565Phase 4Completed
- Start
- Jun 2017
- Modality
- Small Molecules
01
Overview
Phase 4 trial of riociguat in pulmonary arterial hypertension (PAH) (3 arms). Started Jun 2017; status: completed.
02
Drugs
riociguat
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on jRCT1080223565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223565.